Meeting
2024 ASCO Annual Meeting
Expand and pull: A new treatment paradigm for glioblastoma using a long-acting recombinant interleukin-7 and oncolytic viral therapy.
Authors
Yuping Derek Li
Washington University School of Medicine in St. Louis, Saint Louis, MO
Yuping Derek Li , Tong Hu , Ashwani Kesarwani , Amanda Costa , Alexandra Wolfarth , Sara Ferrando-Martinez , Byung Ha Lee , Michael Diamond , Milan G Chheda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 2043)
DOI
10.1200/JCO.2024.42.16_suppl.2043
Abstract #
2043
Poster Bd #
342
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Association of increased progression-free survival in primary glioblastomas with lymphopenia at baseline and activation of NK and NKT cells after dendritic cell immunotherapy.
First Author: Marica Eoli
Poster
2024 ASCO Annual Meeting
Pan-cancer B- and T-cell transcriptome analysis of CXCL13 as a predictive marker for immune checkpoint inhibitor response.
First Author: Yu Fujiwara
Poster
2024 ASCO Annual Meeting
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.
First Author: Soumya Shekhar
Poster
2024 ASCO Genitourinary Cancers Symposium
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment.
First Author: Mitch Hayes